23.08
-0.02(-0.09%)
Currency In USD
| Previous Close | 23.1 |
| Open | 22.85 |
| Day High | 23.23 |
| Day Low | 22.6 |
| 52-Week High | 26.58 |
| 52-Week Low | 19.05 |
| Volume | 917,885 |
| Average Volume | 1.43M |
| Market Cap | 2.84B |
| PE | 13.5 |
| EPS | 1.71 |
| Moving Average 50 Days | 21.48 |
| Moving Average 200 Days | 22.04 |
| Change | -0.02 |
If you invested $1000 in Catalyst Pharmaceuticals, Inc. (CPRX) 10 years ago, it would be worth $9,122.53 as of December 04, 2025 at a share price of $23.08. Whereas If you bought $1000 worth of Catalyst Pharmaceuticals, Inc. (CPRX) shares 5 years ago, it would be worth $6,428.97 as of December 04, 2025 at a share price of $23.08.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
GlobeNewswire Inc.
Nov 24, 2025 1:03 PM GMT
CORAL GABLES, Fla., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for
Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™
GlobeNewswire Inc.
Nov 19, 2025 1:03 PM GMT
Attributes 249% Revenue Growth to Portfolio Momentum and Focused ExecutionCORAL GABLES, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company fo
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
GlobeNewswire Inc.
Nov 18, 2025 1:03 PM GMT
CORAL GABLES, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for